Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biomarin Pharmaceut (BMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,671,980
  • Shares Outstanding, K 177,590
  • Annual Sales, $ 1,314 M
  • Annual Income, $ -117,040 K
  • 36-Month Beta 1.61
  • Price/Sales 13.15
  • Price/Cash Flow N/A
  • Price/Book 5.99

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.05
  • Number of Estimates 3
  • High Estimate -0.02
  • Low Estimate -0.07
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
96.02 +3.63%
on 09/25/18
104.98 -5.21%
on 10/09/18
+0.93 (+0.94%)
since 09/12/18
3-Month
95.16 +4.57%
on 09/04/18
106.20 -6.30%
on 08/07/18
-3.80 (-3.68%)
since 07/12/18
52-Week
75.81 +31.26%
on 04/06/18
106.20 -6.30%
on 08/07/18
+4.38 (+4.60%)
since 10/12/17

Most Recent Stories

More News
NASDAQ Ends Losing Skid as Tech Rebounds

NASDAQ Ends Losing Skid as Tech Rebounds

GWRE : 88.78 (+2.01%)
QCOM : 64.29 (unch)
BMRN : 99.51 (+2.27%)
HTHT : 28.34 (+6.22%)
CSX : 70.20 (+2.08%)
Biomarin Pharmac Set to Possibly Pullback After Yesterday's Rally of 1.64%

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $99.14 to a high of $102.59. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high...

BMRN : 99.51 (+2.27%)
BioMarin to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Thursday, October 25 at 4:30pm ET

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, October 25,...

BMRN : 99.51 (+2.27%)
Dow All Alone in Record Territory

Dow All Alone in Record Territory

BF.B : 46.59 (+1.84%)
UUUU : 3.19 (-0.31%)
BMRN : 99.51 (+2.27%)
SLB : 59.33 (+0.36%)
HTHT : 28.34 (+6.22%)
MATX : 37.69 (-0.26%)
Modis Therapeutics Announces $30M Series A Financing

Modis Therapeutics, Inc., a company developing medicines for patients with rare genetic diseases, announced today a $30M Series A investment led by F-Prime Capital Partners and OrbiMed. Joshua Grass, former...

BMRN : 99.51 (+2.27%)
DMTX : 5.95 (-0.42%)
Stocks Stall Ahead of Hike

Stocks Stall Ahead of Hike

HCA : 133.86 (+1.08%)
SLB : 59.33 (+0.36%)
BMRN : 99.51 (+2.27%)
EDIT : 27.32 (+2.90%)
QHC : 4.05 (+0.75%)
URBN : 38.59 (+1.37%)
After Yesterday's Decline of 1.43%, Biomarin Pharmac Offers Investors Better Value

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $96.38 to a high of $97.45. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of...

BMRN : 99.51 (+2.27%)
BioMarin to Participate in Two Investor Conferences in October

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in two investor conferences this October. To access the events that are accessible by live webcasts, please...

BMRN : 99.51 (+2.27%)
Biomarin Pharmac Set to Possibly Pullback After Yesterday's Rally of 1.53%

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $96.18 to a high of $98.48. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high...

BMRN : 99.51 (+2.27%)
BioMarin Announces 20 Poster Presentations at Society for the Study of Inborn Errors of Metabolism (SSIEM) Symposium 2018

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the company will present 20 poster presentations at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Symposium 2018, which...

BMRN : 99.51 (+2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade BMRN with:

Business Summary

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment...

See More

Key Turning Points

2nd Resistance Point 101.58
1st Resistance Point 100.55
Last Price 99.51
1st Support Level 97.80
2nd Support Level 96.08

See More

52-Week High 106.20
Last Price 99.51
Fibonacci 61.8% 94.59
Fibonacci 50% 91.00
Fibonacci 38.2% 87.42
52-Week Low 75.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar